drugset / Trial / NCT01048268

Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer?

NCT01048268

Phase 1/2 Completed 30 enrolled University Hospital, Gentofte, Copenhagen
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The purpose of this study is to determine whether glucose-dependent insulinotropic polypeptide (GIP) has a stabilizing function on the blood glucose

Timeline

Start
2009-12
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucose-dependent Insulinotropic Polypeptide Peptide 2 unknown Intravenous

Indications